Hemo Organic Ltd — Important, 16-12-2025: Company Update

Hemo Organic has called an Extra-Ordinary General Meeting for shareholders to consider two key proposals. First, to increase the company's authorized share capital from 10 Cr to 13.45 Cr, providing flexibility for future capital needs. Second, to approve a preferential issue of 99.75 lakh convertible warrants at Rs. 12.50 each to non-promoter entities, raising approximately 12.47 Cr. These funds are earmarked for working capital (9.35 Cr) and general corporate purposes (3.12 Cr). The Board seeks shareholder approval for these resolutions to strengthen the company's financial position and support business operations.